# The Efficacy of Single-strain Probiotics in Patients With Irritable Bowel Syndrome

> **NCT05064930** · NA · COMPLETED · sponsor: **Nordic Biotic Sp. z o.o.** · enrollment: 120 (actual)

## Conditions studied

- Irritable Bowel Syndrome

## Interventions

- **DIETARY_SUPPLEMENT:** Probiotic Bifidobacterium lactis
- **DIETARY_SUPPLEMENT:** Probiotic Bacillus coagulans
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT05064930
- **Lead sponsor:** Nordic Biotic Sp. z o.o.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-01
- **Primary completion:** 2022-06-30
- **Final completion:** 2022-07-31
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2023-07-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05064930

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05064930, "The Efficacy of Single-strain Probiotics in Patients With Irritable Bowel Syndrome". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05064930. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*